Figure 3.
Estimated HR as a function of absolute change in glycated hemoglobin (HbA1c; from index to measurement 22–26 months after). Analysis stratified on index HbA1c in five categories. We adjusted for age, sex (male, female), preventive pharmacological treatment of cardiovascular diseases (yes, no), prior cardiovascular disease (yes, no), number of non-cardiovascular disease, index HbA1c, and HbA1c variability. The solid curves indicating adjusted estimates and dashed curves indicating 95% confidence limits. The gray spikes showing the number of people with the given absolute change in HbA1c (N=11 205).